SlideShare une entreprise Scribd logo
1  sur  10
Télécharger pour lire hors ligne
One-stop solution to all bio-data analysis
www.biodebug.com © Bio-Debug UG
“Big data will deliver transformational benefits to enterprises within two to five years, and by 2015,
will enable enterprises adopting this technology to outperform competitors by 20% in every
available financial metric.”
Gartner, 2012
About us Over team.....
Bio-Debug UG
Dr. Rahuman Sheriff
Founder, Cheif Scientist
Germany
Deepak Chandrasekaran
Co-founder, ICEO
Germany
"We are a highly dynamic interactive team working synergistically
to drive your individual projects using a multitude of state-of-the-
art techniques and systems to address your interesting questions.
Our team comprises highly enthusiastic, Bioinformaticians,
genome scientists,biologists, Computer Scientists, engineers,
statisticians and experts in machine learning, data mining and
big data analysis.
We are bridging the gap between bioinformatics and biologists
by close iterative collaboration with multidisciplinary team.
Every project is unique, so methods applied for one project
may not necessarily address the other, Bio-Bedug will offer
custom made solution for the clients." Advisory Board
Prof .Staffan Nilsson
Dept.Pure & Applied Biochemistry,
Lund University, Sweden
Sebastian Hanny
Managing Director,
tu > startup foundation,
Dortmund, Germany
Prof . Aman Russom
School Of Biotechnology,
KTH, Sweden
Technical Team
Ramesh Murthi,
Automation & Robotics
Design
Arunkumar Sugadevan,
IT & Software
Sectors we work with .............
Research and Development
Health Care
Pharma
Biotechnology
Environment
Analysis of NGS (Next
Gen Sequencing) Data.
GNAS- Genome wide association studies
Expression quantitative trait loci (eQTL)
Modeling Expression
Visualize protein networks
Exploring biological signal
RESEARCH & DEVELOPMENT
Recommendation
system in health care
Internet based epidemic survillance
Sensor based health conditions
Metabolomics & ionomics
Sequencing cancer cell lines
Identify cancer biomarkers
HEALTH CARE
M health
Identifying potential therapeutics
Therapeutics
Diagnostics
Food safety monitoring
BIOTECHNOLOGY
Interferring air quality
Effectiveness study
Modelling culture yeild
Selection of new crop
Data driven planting
Hyperlocal weather forecast
ENVIRONMENT
Drug development
PHARMA
Systems we drive .............
incubation
innovation
industrialization
sustainability
Identify key business problems and drive innovation to
develop a solution that produces a proof ofconcept or prototype.
Using the proof of concept, scale the analytics initiative to evaluate
value across larger target beneficiaries and test the model across
additional cycles. Determine whether there are enough benefits
in the project to proceed to the next stage.
Move the solution from proof of concept to validation, deployment and monitoring.
Provide a production scale solution that proves value and benefits.
Maintain the analytics solution. Provide support to
solution consumers and enable continued value delivery.
Functional Area.....
ANALYTICS RESEARCH
AND DISCOVERY
Target/biomarker
identification
Portfolio optimization
CLINICAL
DEVELOPMENT
Trial planning
and efficiency
Clinical trial design
Cohort identification
and segmentation
Safety monitoring
Forecasting
Scenario
planning
MANUFACTURING
AND SUPPLY CHAIN
Supplier
compliance
Inventory
management
Demand planning
and forecasting
Manufacturing asset
productivity &
effectiveness
SALES AND
MARKETING
Managed markets
analytics
Customer segmentation
Sales force effectiveness
Marketing channel analysis
Pricing optimization
Outcomes optimization
Corporate office
Bio-Debug UG
Technologiezentrum Dortmund,
Emil-Figge-Straße 76 - 80,
44227 Dortmund
+49 - 15226884545
Information Center 1
Bio-Debug info center
Uniter Kingdom
Information Center 2
Bio-Debug info center
Chennai
Write to us info@biodebug.com

Contenu connexe

Tendances

ValGenesis Case Study With Scinopharm -Paperless Validation Software Solution
ValGenesis Case Study With Scinopharm -Paperless Validation Software Solution ValGenesis Case Study With Scinopharm -Paperless Validation Software Solution
ValGenesis Case Study With Scinopharm -Paperless Validation Software Solution ValGenesis
 
Dismantling Barriers to Adaptive Design Adoption to Be Key Theme of Pre-Disru...
Dismantling Barriers to Adaptive Design Adoption to Be Key Theme of Pre-Disru...Dismantling Barriers to Adaptive Design Adoption to Be Key Theme of Pre-Disru...
Dismantling Barriers to Adaptive Design Adoption to Be Key Theme of Pre-Disru...ConferenceForum
 
The Perils of Clinical Trial Budgeting
The Perils of Clinical Trial BudgetingThe Perils of Clinical Trial Budgeting
The Perils of Clinical Trial BudgetingPerficient
 
Test og innovationsmiljøer flyer ENG
Test og innovationsmiljøer flyer ENGTest og innovationsmiljøer flyer ENG
Test og innovationsmiljøer flyer ENGMarie Klintrup
 
Getting to Approval Faster Through Technology Innovation
Getting to Approval Faster Through Technology InnovationGetting to Approval Faster Through Technology Innovation
Getting to Approval Faster Through Technology InnovationPAREXEL International
 
BigDataAnalytics_Talk_KOCH_FINAL
BigDataAnalytics_Talk_KOCH_FINALBigDataAnalytics_Talk_KOCH_FINAL
BigDataAnalytics_Talk_KOCH_FINALJohn Koch
 
Clinical research innovation hub slides for kelly
Clinical research innovation hub slides for kellyClinical research innovation hub slides for kelly
Clinical research innovation hub slides for kellyRyan Tubbs
 
CISummit 2013: Steve Gullans & Gregory Gallo, The BioSimilar Age: How to Prom...
CISummit 2013: Steve Gullans & Gregory Gallo, The BioSimilar Age: How to Prom...CISummit 2013: Steve Gullans & Gregory Gallo, The BioSimilar Age: How to Prom...
CISummit 2013: Steve Gullans & Gregory Gallo, The BioSimilar Age: How to Prom...Steven Wardell
 
Kestrel i qros description 1 page - intro
Kestrel i qros description   1 page - introKestrel i qros description   1 page - intro
Kestrel i qros description 1 page - introLorne Cheeseman
 
Vaccine delivery and affordability are major bottlenecks
Vaccine delivery and affordability are major bottlenecksVaccine delivery and affordability are major bottlenecks
Vaccine delivery and affordability are major bottleneckshillemanlabs
 
SB11 - Chemrisk - Julie Panko
SB11 - Chemrisk - Julie Panko SB11 - Chemrisk - Julie Panko
SB11 - Chemrisk - Julie Panko Sustainable Brands
 
7 Steps for Boosting R&D Outcomes
7 Steps for Boosting R&D Outcomes7 Steps for Boosting R&D Outcomes
7 Steps for Boosting R&D OutcomesTamrMarketing
 
Improving search efficiency for economic evaluations in major databases using...
Improving search efficiency for economic evaluations in major databases using...Improving search efficiency for economic evaluations in major databases using...
Improving search efficiency for economic evaluations in major databases using...York Health Economics Consortium (YHEC)
 
Accelrys Discovery Studio 3.1
Accelrys Discovery Studio 3.1Accelrys Discovery Studio 3.1
Accelrys Discovery Studio 3.1BIOVIA
 
TSRL Fact Sheet_Preclinical Accelerator_June 2016
TSRL Fact Sheet_Preclinical Accelerator_June 2016TSRL Fact Sheet_Preclinical Accelerator_June 2016
TSRL Fact Sheet_Preclinical Accelerator_June 2016Drew Hertig, MBA, CLP
 
Screening Data Exchange Standards
Screening Data Exchange StandardsScreening Data Exchange Standards
Screening Data Exchange StandardsPistoia Alliance
 
Tsrl modified dosage forms august_non-confidential
Tsrl modified dosage forms august_non-confidentialTsrl modified dosage forms august_non-confidential
Tsrl modified dosage forms august_non-confidentialDrew Hertig, MBA, CLP
 
Introduction to the TSRL, Inc. Accelerator Model
Introduction to the TSRL, Inc. Accelerator ModelIntroduction to the TSRL, Inc. Accelerator Model
Introduction to the TSRL, Inc. Accelerator ModelDrew Hertig, MBA, CLP
 
Hirshberg promise of digital technology astra_zenecaThe Promise of Digital Te...
Hirshberg promise of digital technology astra_zenecaThe Promise of Digital Te...Hirshberg promise of digital technology astra_zenecaThe Promise of Digital Te...
Hirshberg promise of digital technology astra_zenecaThe Promise of Digital Te...Levi Shapiro
 

Tendances (20)

ValGenesis Case Study With Scinopharm -Paperless Validation Software Solution
ValGenesis Case Study With Scinopharm -Paperless Validation Software Solution ValGenesis Case Study With Scinopharm -Paperless Validation Software Solution
ValGenesis Case Study With Scinopharm -Paperless Validation Software Solution
 
Dismantling Barriers to Adaptive Design Adoption to Be Key Theme of Pre-Disru...
Dismantling Barriers to Adaptive Design Adoption to Be Key Theme of Pre-Disru...Dismantling Barriers to Adaptive Design Adoption to Be Key Theme of Pre-Disru...
Dismantling Barriers to Adaptive Design Adoption to Be Key Theme of Pre-Disru...
 
The Perils of Clinical Trial Budgeting
The Perils of Clinical Trial BudgetingThe Perils of Clinical Trial Budgeting
The Perils of Clinical Trial Budgeting
 
Test og innovationsmiljøer flyer ENG
Test og innovationsmiljøer flyer ENGTest og innovationsmiljøer flyer ENG
Test og innovationsmiljøer flyer ENG
 
Getting to Approval Faster Through Technology Innovation
Getting to Approval Faster Through Technology InnovationGetting to Approval Faster Through Technology Innovation
Getting to Approval Faster Through Technology Innovation
 
BigDataAnalytics_Talk_KOCH_FINAL
BigDataAnalytics_Talk_KOCH_FINALBigDataAnalytics_Talk_KOCH_FINAL
BigDataAnalytics_Talk_KOCH_FINAL
 
Clinical research innovation hub slides for kelly
Clinical research innovation hub slides for kellyClinical research innovation hub slides for kelly
Clinical research innovation hub slides for kelly
 
CISummit 2013: Steve Gullans & Gregory Gallo, The BioSimilar Age: How to Prom...
CISummit 2013: Steve Gullans & Gregory Gallo, The BioSimilar Age: How to Prom...CISummit 2013: Steve Gullans & Gregory Gallo, The BioSimilar Age: How to Prom...
CISummit 2013: Steve Gullans & Gregory Gallo, The BioSimilar Age: How to Prom...
 
Kestrel i qros description 1 page - intro
Kestrel i qros description   1 page - introKestrel i qros description   1 page - intro
Kestrel i qros description 1 page - intro
 
Vaccine delivery and affordability are major bottlenecks
Vaccine delivery and affordability are major bottlenecksVaccine delivery and affordability are major bottlenecks
Vaccine delivery and affordability are major bottlenecks
 
SB11 - Chemrisk - Julie Panko
SB11 - Chemrisk - Julie Panko SB11 - Chemrisk - Julie Panko
SB11 - Chemrisk - Julie Panko
 
7 Steps for Boosting R&D Outcomes
7 Steps for Boosting R&D Outcomes7 Steps for Boosting R&D Outcomes
7 Steps for Boosting R&D Outcomes
 
Molecular Sensor from SCIO
Molecular Sensor from SCIOMolecular Sensor from SCIO
Molecular Sensor from SCIO
 
Improving search efficiency for economic evaluations in major databases using...
Improving search efficiency for economic evaluations in major databases using...Improving search efficiency for economic evaluations in major databases using...
Improving search efficiency for economic evaluations in major databases using...
 
Accelrys Discovery Studio 3.1
Accelrys Discovery Studio 3.1Accelrys Discovery Studio 3.1
Accelrys Discovery Studio 3.1
 
TSRL Fact Sheet_Preclinical Accelerator_June 2016
TSRL Fact Sheet_Preclinical Accelerator_June 2016TSRL Fact Sheet_Preclinical Accelerator_June 2016
TSRL Fact Sheet_Preclinical Accelerator_June 2016
 
Screening Data Exchange Standards
Screening Data Exchange StandardsScreening Data Exchange Standards
Screening Data Exchange Standards
 
Tsrl modified dosage forms august_non-confidential
Tsrl modified dosage forms august_non-confidentialTsrl modified dosage forms august_non-confidential
Tsrl modified dosage forms august_non-confidential
 
Introduction to the TSRL, Inc. Accelerator Model
Introduction to the TSRL, Inc. Accelerator ModelIntroduction to the TSRL, Inc. Accelerator Model
Introduction to the TSRL, Inc. Accelerator Model
 
Hirshberg promise of digital technology astra_zenecaThe Promise of Digital Te...
Hirshberg promise of digital technology astra_zenecaThe Promise of Digital Te...Hirshberg promise of digital technology astra_zenecaThe Promise of Digital Te...
Hirshberg promise of digital technology astra_zenecaThe Promise of Digital Te...
 

Similaire à rev_2 (1) (3)

HealthBIO 2021_PerkinElmer, leading with innovation - from COVID success into...
HealthBIO 2021_PerkinElmer, leading with innovation - from COVID success into...HealthBIO 2021_PerkinElmer, leading with innovation - from COVID success into...
HealthBIO 2021_PerkinElmer, leading with innovation - from COVID success into...Business Turku
 
The most recommended pharma & life sciences solution providers in 2021
The most recommended pharma & life sciences solution providers in 2021The most recommended pharma & life sciences solution providers in 2021
The most recommended pharma & life sciences solution providers in 2021The Business Fame Magazine
 
Discovery and validation with scientific method - the Lean Startup approach
Discovery and validation with scientific method - the Lean Startup approachDiscovery and validation with scientific method - the Lean Startup approach
Discovery and validation with scientific method - the Lean Startup approachMilan Zdravković
 
Big data cognitive computing and digital transformation
Big data cognitive computing and digital transformationBig data cognitive computing and digital transformation
Big data cognitive computing and digital transformationPietro Leo
 
The Digital Thread for Life Sciences | Accenture
The Digital Thread for Life Sciences | AccentureThe Digital Thread for Life Sciences | Accenture
The Digital Thread for Life Sciences | Accentureaccenture
 
Creme Global - Aggregate Exposure - Data Science - Introduction
Creme Global - Aggregate Exposure - Data Science - IntroductionCreme Global - Aggregate Exposure - Data Science - Introduction
Creme Global - Aggregate Exposure - Data Science - IntroductionCronan McNamara
 
Data Use Cases - Healthcare & Banking3.pptx
Data Use Cases - Healthcare & Banking3.pptxData Use Cases - Healthcare & Banking3.pptx
Data Use Cases - Healthcare & Banking3.pptxDimple N Rakhiani
 
The 10 most innovative bio tech solution providers
The 10 most innovative bio tech solution providersThe 10 most innovative bio tech solution providers
The 10 most innovative bio tech solution providersMerry D'souza
 
The Future of Bioprocessing – What you need to know.
The Future of Bioprocessing – What you need to know.The Future of Bioprocessing – What you need to know.
The Future of Bioprocessing – What you need to know.Merck Life Sciences
 
Best Practices for Building an End-to-End Workflow for Microbial Genomics
 Best Practices for Building an End-to-End Workflow for Microbial Genomics Best Practices for Building an End-to-End Workflow for Microbial Genomics
Best Practices for Building an End-to-End Workflow for Microbial GenomicsJonathan Jacobs, PhD
 
40 Artificial Intelligence Companies Improving Healthcare (I-Square Ventures)
40 Artificial Intelligence Companies Improving Healthcare (I-Square Ventures)40 Artificial Intelligence Companies Improving Healthcare (I-Square Ventures)
40 Artificial Intelligence Companies Improving Healthcare (I-Square Ventures)Chiranjeev Bordoloi
 
Transforming Big Data into Big Value
Transforming Big Data into Big ValueTransforming Big Data into Big Value
Transforming Big Data into Big ValueThomas Kelly, PMP
 
sbv IMPROVER: an industry initiative to harness the wisdom of the crowd in sc...
sbv IMPROVER: an industry initiative to harness the wisdom of the crowd in sc...sbv IMPROVER: an industry initiative to harness the wisdom of the crowd in sc...
sbv IMPROVER: an industry initiative to harness the wisdom of the crowd in sc...Crowdsourcing Week
 
PCT Presentation Shared October 2016
PCT Presentation Shared October 2016PCT Presentation Shared October 2016
PCT Presentation Shared October 2016Cenk Sumen
 
의료의 미래, 디지털 헬스케어 + 의료 시장의 특성
의료의 미래, 디지털 헬스케어 + 의료 시장의 특성의료의 미래, 디지털 헬스케어 + 의료 시장의 특성
의료의 미래, 디지털 헬스케어 + 의료 시장의 특성Yoon Sup Choi
 
Dr. Walter Greenleaf's presentation for the IVRHA Meeting -August 2020
Dr. Walter Greenleaf's presentation for the IVRHA Meeting -August 2020Dr. Walter Greenleaf's presentation for the IVRHA Meeting -August 2020
Dr. Walter Greenleaf's presentation for the IVRHA Meeting -August 2020Stanford University
 
SILS 2015 - Innovation at GE Healthcare
SILS 2015 - Innovation at GE HealthcareSILS 2015 - Innovation at GE Healthcare
SILS 2015 - Innovation at GE HealthcareSherbrooke Innopole
 
Real time modeling system
Real time modeling systemReal time modeling system
Real time modeling systemGBX Summits
 

Similaire à rev_2 (1) (3) (20)

HealthBIO 2021_PerkinElmer, leading with innovation - from COVID success into...
HealthBIO 2021_PerkinElmer, leading with innovation - from COVID success into...HealthBIO 2021_PerkinElmer, leading with innovation - from COVID success into...
HealthBIO 2021_PerkinElmer, leading with innovation - from COVID success into...
 
The most recommended pharma & life sciences solution providers in 2021
The most recommended pharma & life sciences solution providers in 2021The most recommended pharma & life sciences solution providers in 2021
The most recommended pharma & life sciences solution providers in 2021
 
Discovery and validation with scientific method - the Lean Startup approach
Discovery and validation with scientific method - the Lean Startup approachDiscovery and validation with scientific method - the Lean Startup approach
Discovery and validation with scientific method - the Lean Startup approach
 
Strand genomics features in CIO review
Strand genomics features in CIO reviewStrand genomics features in CIO review
Strand genomics features in CIO review
 
Big data cognitive computing and digital transformation
Big data cognitive computing and digital transformationBig data cognitive computing and digital transformation
Big data cognitive computing and digital transformation
 
The Digital Thread for Life Sciences | Accenture
The Digital Thread for Life Sciences | AccentureThe Digital Thread for Life Sciences | Accenture
The Digital Thread for Life Sciences | Accenture
 
Creme Global - Aggregate Exposure - Data Science - Introduction
Creme Global - Aggregate Exposure - Data Science - IntroductionCreme Global - Aggregate Exposure - Data Science - Introduction
Creme Global - Aggregate Exposure - Data Science - Introduction
 
Data Use Cases - Healthcare & Banking3.pptx
Data Use Cases - Healthcare & Banking3.pptxData Use Cases - Healthcare & Banking3.pptx
Data Use Cases - Healthcare & Banking3.pptx
 
The 10 most innovative bio tech solution providers
The 10 most innovative bio tech solution providersThe 10 most innovative bio tech solution providers
The 10 most innovative bio tech solution providers
 
The Future of Bioprocessing – What you need to know.
The Future of Bioprocessing – What you need to know.The Future of Bioprocessing – What you need to know.
The Future of Bioprocessing – What you need to know.
 
Best Practices for Building an End-to-End Workflow for Microbial Genomics
 Best Practices for Building an End-to-End Workflow for Microbial Genomics Best Practices for Building an End-to-End Workflow for Microbial Genomics
Best Practices for Building an End-to-End Workflow for Microbial Genomics
 
40 Artificial Intelligence Companies Improving Healthcare (I-Square Ventures)
40 Artificial Intelligence Companies Improving Healthcare (I-Square Ventures)40 Artificial Intelligence Companies Improving Healthcare (I-Square Ventures)
40 Artificial Intelligence Companies Improving Healthcare (I-Square Ventures)
 
Transforming Big Data into Big Value
Transforming Big Data into Big ValueTransforming Big Data into Big Value
Transforming Big Data into Big Value
 
sbv IMPROVER: an industry initiative to harness the wisdom of the crowd in sc...
sbv IMPROVER: an industry initiative to harness the wisdom of the crowd in sc...sbv IMPROVER: an industry initiative to harness the wisdom of the crowd in sc...
sbv IMPROVER: an industry initiative to harness the wisdom of the crowd in sc...
 
MDEM Book
MDEM BookMDEM Book
MDEM Book
 
PCT Presentation Shared October 2016
PCT Presentation Shared October 2016PCT Presentation Shared October 2016
PCT Presentation Shared October 2016
 
의료의 미래, 디지털 헬스케어 + 의료 시장의 특성
의료의 미래, 디지털 헬스케어 + 의료 시장의 특성의료의 미래, 디지털 헬스케어 + 의료 시장의 특성
의료의 미래, 디지털 헬스케어 + 의료 시장의 특성
 
Dr. Walter Greenleaf's presentation for the IVRHA Meeting -August 2020
Dr. Walter Greenleaf's presentation for the IVRHA Meeting -August 2020Dr. Walter Greenleaf's presentation for the IVRHA Meeting -August 2020
Dr. Walter Greenleaf's presentation for the IVRHA Meeting -August 2020
 
SILS 2015 - Innovation at GE Healthcare
SILS 2015 - Innovation at GE HealthcareSILS 2015 - Innovation at GE Healthcare
SILS 2015 - Innovation at GE Healthcare
 
Real time modeling system
Real time modeling systemReal time modeling system
Real time modeling system
 

rev_2 (1) (3)

  • 1. One-stop solution to all bio-data analysis www.biodebug.com © Bio-Debug UG
  • 2. “Big data will deliver transformational benefits to enterprises within two to five years, and by 2015, will enable enterprises adopting this technology to outperform competitors by 20% in every available financial metric.” Gartner, 2012
  • 3. About us Over team..... Bio-Debug UG Dr. Rahuman Sheriff Founder, Cheif Scientist Germany Deepak Chandrasekaran Co-founder, ICEO Germany "We are a highly dynamic interactive team working synergistically to drive your individual projects using a multitude of state-of-the- art techniques and systems to address your interesting questions. Our team comprises highly enthusiastic, Bioinformaticians, genome scientists,biologists, Computer Scientists, engineers, statisticians and experts in machine learning, data mining and big data analysis. We are bridging the gap between bioinformatics and biologists by close iterative collaboration with multidisciplinary team. Every project is unique, so methods applied for one project may not necessarily address the other, Bio-Bedug will offer custom made solution for the clients." Advisory Board Prof .Staffan Nilsson Dept.Pure & Applied Biochemistry, Lund University, Sweden Sebastian Hanny Managing Director, tu > startup foundation, Dortmund, Germany Prof . Aman Russom School Of Biotechnology, KTH, Sweden Technical Team Ramesh Murthi, Automation & Robotics Design Arunkumar Sugadevan, IT & Software
  • 4. Sectors we work with .............
  • 5. Research and Development Health Care Pharma Biotechnology Environment
  • 6. Analysis of NGS (Next Gen Sequencing) Data. GNAS- Genome wide association studies Expression quantitative trait loci (eQTL) Modeling Expression Visualize protein networks Exploring biological signal RESEARCH & DEVELOPMENT Recommendation system in health care Internet based epidemic survillance Sensor based health conditions Metabolomics & ionomics Sequencing cancer cell lines Identify cancer biomarkers HEALTH CARE M health Identifying potential therapeutics Therapeutics Diagnostics Food safety monitoring BIOTECHNOLOGY Interferring air quality Effectiveness study Modelling culture yeild Selection of new crop Data driven planting Hyperlocal weather forecast ENVIRONMENT Drug development PHARMA
  • 7. Systems we drive .............
  • 8. incubation innovation industrialization sustainability Identify key business problems and drive innovation to develop a solution that produces a proof ofconcept or prototype. Using the proof of concept, scale the analytics initiative to evaluate value across larger target beneficiaries and test the model across additional cycles. Determine whether there are enough benefits in the project to proceed to the next stage. Move the solution from proof of concept to validation, deployment and monitoring. Provide a production scale solution that proves value and benefits. Maintain the analytics solution. Provide support to solution consumers and enable continued value delivery.
  • 9. Functional Area..... ANALYTICS RESEARCH AND DISCOVERY Target/biomarker identification Portfolio optimization CLINICAL DEVELOPMENT Trial planning and efficiency Clinical trial design Cohort identification and segmentation Safety monitoring Forecasting Scenario planning MANUFACTURING AND SUPPLY CHAIN Supplier compliance Inventory management Demand planning and forecasting Manufacturing asset productivity & effectiveness SALES AND MARKETING Managed markets analytics Customer segmentation Sales force effectiveness Marketing channel analysis Pricing optimization Outcomes optimization
  • 10. Corporate office Bio-Debug UG Technologiezentrum Dortmund, Emil-Figge-Straße 76 - 80, 44227 Dortmund +49 - 15226884545 Information Center 1 Bio-Debug info center Uniter Kingdom Information Center 2 Bio-Debug info center Chennai Write to us info@biodebug.com